CLSA Board of Directors
Officers

William J. Newell
Chair
Chief Executive Officer, Sutro Biopharma, Inc.

Melinda Richter
Vice Chair
Global Head, Johnson & Johnson Innovation, JLABS

Alex Kelly
Treasurer
Executive Vice President, Corporate Affairs and Chief Communications Officer, Allergan

Bruce W. Jenett
Secretary
Senior Counsel, DLA Piper LLP (US)
Members

Wade Ackerman
Partner, Covington & Burling LLP

William Annett
Chief Executive Officer OncoCyte

Michael V. Arbige, Ph.D.
Vice President of R&D, DuPont Biosciences

Rick Ascroft
Senior Vice President, Managed Markets, Takeda Pharmaceuticals USA

Ranjeet Banerjee
Worldwide President, Medication Management Solutions, Becton, Dickinson And Company (BD)

David Beier, J.D.
Managing Director, Bay City Capital

Fritz Bittenbender
Senior Vice President, Government Affairs, Genentech

Donald E. Bobo, Jr.
Corporate Vice President, Strategy & Corporate Development, Edwards Lifesciences

Ho Sung Cho
Vice President, Biotherapeutics, Celgene

Peter J. Claude
Partner, PwC

David H. Crean
Managing Director & Partner, Objective Capital Partners

Mark Ginestro
Principal, Healthcare and Life Sciences, KPMG

Bryan Giraudo
Chief Financial Officer, Gossamer Bio

Paul Hastings
President and Chief Executive Officer, Nkarta Therapeutics

Thomas Hudson
Vice President, Head of Oncology Discovery and Early Development, AbbVie, Inc.

Vera Janushkowsky
Vice President, Government Relations and Public Affairs, Pfizer

Jeff Jonker
President and CEO, Ambys Medicines

Steve A. Kay, Ph.D., D.Sc.
Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California

Larry Kwak, M.D., Ph.D.
Vice President and Cancer Center Associate Director
Director, Toni Stephenson Lymphoma Center

John Maddalon
Principal, Life Science Practice, Deloitte

Sean McCarthy
President and Chief Executive Officer, CytomX

Shlomo Melmed, MB, ChB, MACP
Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

John Melo
Director, President and Chief Executive Officer, Amyris

Alan Mendelson
Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP

Keith Murphy
Founder, CEO, and Chairman, Viscient Biosciences

John Nicols
President and Chief Executive Officer, Codexis

Christian W. Nolet
Partner and Life Sciences Industry Leader, West Region, Ernst & Young

Joshua J. Ofman M.D., M.S.H.S
Senior Vice President, Global Value, Access & Policy, Amgen

Michael G. Raab
President and Chief Executive Officer, Ardelyx

Ganesh Raman, Ph.D.
Associate Vice Chancellor for Research, California State University

Stephen Richardson
Co-Chief Executive Officer, Alexandria Real Estate (ARE)

Beth Roberts
Partner, Hogan Lovells US LLP

Daria Mochly-Rosen, Ph.D.
The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine

Terry Rosen, Ph.D.
Chief Executive Officer, Arcus Biosciences

George Savage M.D.
Co-Founder, Chief Medical Officer, Proteus Digital Health

Tony Semedo
President, Medtronic Japan

Alex Szidon
Head of West Coast Business Development & Licensing, Merck

Harold E. Van Wart, Ph.D.

Jens Vogel, Ph.D.
President and CEO | Boehringer Ingelheim

Jared Watkin
Senior Vice President, Diabetes Care, Abbott

Rick E Winningham
Chairman and CEO, Theravance Biopharma